Becker's Healthcare May 16, 2023
Jakob Emerson

Malignant neoplasms accounted for the most expensive claims for self-insured employers in 2022 and during the last four years, according to a May report from Sun Life, a life and health insurance provider.

Sun Life analyzed four years of claims from 2019 through 2022, representing more than 55,000 members, $5.5B in total reimbursements, and $12.2B in total cost. The data set includes the full Sun Life. The top 10 conditions were found to be responsible for 71 percent of all stop-loss claims.

Highest-cost claim conditions based on stop-loss claim reimbursements:

1. Malignant Neoplasm
2022: $324.8 million
2019-2022: $1.13 billion

2. Leukemia, Lymphoma, Multiple Myeloma
2022: $115.2 million
2019-2022: $462.5 million

3. Cardiovascular
2022: $142.4 million
2019-2022: $443.8 million

4. Orthopedics/Musculoskeletal
2022:...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Self-insured, Survey / Study, Trends
Transcarent unveils new gen AI-enabled platform WayFinding
Quantum Health Launches New Pharmacy Navigation Solution for Employers
Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is a Possibility
'Podnosis': Inside Morgan Health's investment strategy and the art of the pitch
Q&A: Brittany Cunningham on Vanderbilt’s MyHealth Bundles Program

Share This Article